Systematic review of erythropoiesis-stimulating agent dosing algorithms in hemodialysis patients

被引:0
|
作者
Meaney, Calvin [1 ]
Gaesser, Jamie [2 ]
Robinson, Ben [2 ]
Krzyzanski, Wojciech [2 ]
Panesar, Mandip [3 ]
Rao, Gauri [4 ]
机构
[1] SUNY Buffalo, Dept Pharm Practice, Sch Pharm & Pharmaceut Sci, Buffalo, NY USA
[2] SUNY Buffalo, Sch Pharm & Pharmaceut Sci, Buffalo, NY USA
[3] Erie Cty Med Ctr & Labs, Buffalo, NY USA
[4] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Experiential Educ, Chapel Hill, NC USA
来源
PHARMACOTHERAPY | 2017年 / 37卷 / 12期
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
537
引用
收藏
页码:E235 / E236
页数:2
相关论文
共 50 条
  • [21] The effect of altitude on erythropoiesis-stimulating agent dose, hemoglobin level, and mortality in hemodialysis patients
    Scott Sibbel
    Bradley J. Maroni
    Steven M. Brunelli
    Journal of Nephrology, 2017, 30 : 821 - 829
  • [22] Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients
    Regidor, Deborah L.
    Kopple, Joel D.
    Kovesdy, Csaba P.
    Kilpatrick, Ryan D.
    McAllister, Charles J.
    Aronovitz, Jason
    Greenland, Sander
    Kalantar-Zadeh, Kamyar
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (04): : 1181 - 1191
  • [23] Systematic review of the impact of erythropoiesis-stimulating agents on fatigue in dialysis patients
    Johansen, Kirsten L.
    Finkelstein, Fredric O.
    Revicki, Dennis A.
    Evans, Christopher
    Wan, Shaowei
    Gitlin, Matthew
    Agodoa, Irene L.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (06) : 2418 - 2425
  • [24] Investigating the relationship between erythropoiesis-stimulating agents and mortality in hemodialysis patients: A systematic review and meta-analysis
    Karimi, Zahra
    Raeisi Shahraki, Hadi
    Mohammadian-Hafshejani, Abdollah
    PLOS ONE, 2023, 18 (11):
  • [25] Selenium Associates With Response to Erythropoiesis-Stimulating Agents in Hemodialysis Patients
    Yasukawa, Minoru
    Arai, Shigeyuki
    Nagura, Michito
    Kido, Ryo
    Asakawa, Shinichiro
    Hirohama, Daigoro
    Yamazaki, Osamu
    Tamura, Yoshifuru
    Fujimaki, Michitaka
    Kobayashi, Sawako
    Mimaki, Masakazu
    Kodama, Hiroko
    Uchida, Shunya
    Fujigaki, Yoshihide
    Shibata, Shigeru
    KIDNEY INTERNATIONAL REPORTS, 2022, 7 (07): : 1565 - 1574
  • [27] Comparison of Patient Survival According to Erythropoiesis-Stimulating Agent Type of Treatment in Maintenance Hemodialysis Patients
    Kang, Seok Hui
    Kim, Bo Yeon
    Son, Eun Jung
    Kim, Gui Ok
    Do, Jun Young
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (02)
  • [28] Sickle Trait in African-American Hemodialysis Patients and Higher Erythropoiesis-Stimulating Agent Dose
    Derebail, Vimal K.
    Lacson, Eduardo K., Jr.
    Kshirsagar, Abhijit V.
    Key, Nigel S.
    Hogan, Susan L.
    Hakim, Raymond M.
    Mooney, Ann
    Jani, Chinu M.
    Johnson, Curtis
    Hu, Yichun
    Falk, Ronald J.
    Lazarus, J. Michael
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 25 (04): : 819 - 826
  • [29] Extremely Low Dose of Erythropoiesis-Stimulating Agent May Be Associated with Increased Mortality in Hemodialysis Patients
    Yang, Cheng-Wen
    Lin, Mei-Chen
    Shu, Kai-Hsiang
    Tung, Kuei-Tung
    Tsai, Wan-Chuan
    Yang, Ju-Yeh
    Pai, Mei-Fen
    Wu, Hon-Yen
    Chiu, Yen-Ling
    Peng, Yu-Sen
    Hsu, Shih-Ping
    Wang, Shi-Heng
    Pan, Szu-Yu
    AMERICAN JOURNAL OF NEPHROLOGY, 2023, 54 (1-2) : 25 - 34
  • [30] Parathyroidectomy Improves the Consumption of Erythropoiesis-Stimulating Agents in Hemodialysis Patients
    Lee, Yu-Ting
    Tu, Chi-Wen
    Kam, Kam-Hong
    Ma, Tsung-Liang
    Kuo, Chin-Ho
    Lee, Ming-Yang
    Hsiao, Chih-Yen
    Chan, Michael W. Y.
    Hung, Peir-Haur
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)